Advertisement
YOU ARE HERE: LAT HomeCollections

Business Briefing / PHARMACEUTICALS

Amgen releases drug trial results

July 26, 2008|From Times Staff and Wire Reports

Amgen Inc. said its experimental osteoporosis drug denosumab reduced fractures in women with the bone-thinning disease in a study.

The trial of 7,800 women with osteoporosis found that denosumab strengthened bones and reduced spinal and hip fractures, the Thousand Oaks-based company said.

Advertisement
Los Angeles Times Articles
|
|
|